产品详情
Targets
Target | Value |
---|---|
RET | IC50: 1.5nM |
Raf-1 | IC50: 2.5nM |
VEGFR2 | IC50: 4.2nM |
Kit | IC50: 7nM |
VEGFR1 | IC50: 13nM |
B-Raf(V600E) | IC50: 19nM |
PDGFRβ | IC50: 22nM |
B-Raf | IC50: 28nM |
VEGFR3 | IC50: 46nM |
FGFR1 | IC50: 202nM |
Tie-2 | IC50: 311nM |
In vitro (25°C) | DMSO | 88 mg/mL (182.26 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 2% DMSO+30% PEG 300+5% Tween 80+ddH2O | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.71 mL | 103.56 mL | 207.13 mL |
0.5 mM | 4.14 mL | 20.71 mL | 41.43 mL |
1 mM | 2.07 mL | 10.36 mL | 20.71 mL |
5 mM | 0.41 mL | 2.07 mL | 4.14 mL |
*The above data is based on the productmolecular weight 482.8. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10250 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 482.8 |
Formula | C21H15ClF4N4O3 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 755037-03-7 |
SMILES | CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F |
产品资料
产品标签
Product Questions
Product Questions
Linifanib (ABT-869)
Linifanib (ABT-869)是一种结构新颖的有效RTK,VEGF和PDGF抑制剂,对人内皮细胞,PDGFR-β,KDR和CSF-1R的IC50分别为0.…
B-Raf-inhibitor 1
B-Raf inhibitor 1是有效的选择性B-Raf抑制剂,对A375增殖和A375 p-ERK的细胞IC50分别为0.31 uM和2 nM。
Telatinib (BAY 57-9352)
Telatinib (BAY 57-9352)是一种口服的血管内皮生长因子受体2和3(VEGFR2/3)和血小板衍生的生长因子受体β酪氨酸…